When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA panel says Vertex/CRISPR to assess safety risks of ... - AOL

   www.aol.com/news/fda-panel-says-vertex-crispr...

   The panel members said the 15-year follow up will help generate data from real-time monitoring of the therapy, which uses the new gene editing CRISPR technology.

3. Is Vertex Pharmaceuticals a Buy Now That the FDA ... - AOL

   www.aol.com/vertex-pharmaceuticals-buy-now-fda...

   Casgevy is a one-and-done treatment that Vertex is marketing and developing in partnership with CRISPR Therapeutics (NASDAQ: CRSP). As a treatment administered only once, it carries an enormous $2 ...

4. Sickle cell patients share delight over approval of new treatment

   www.aol.com/sickle-cell-patients-share-delight...

   Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. It works by editing the ...

5. CRISPR gene editing - Wikipedia

   en.wikipedia.org/wiki/CRISPR_gene_editing

   CRISPR-Cas9. CRISPR gene editing (CRISPR, pronounced / ˈ k r ɪ s p ə r / (crisper), refers to a clustered regularly interspaced short palindromic repeats") is a genetic engineering technique in molecular biology by which the genomes of living organisms may be modified.

6. CRISPR - Wikipedia

   en.wikipedia.org/wiki/CRISPR

   Cas9 (or "CRISPR-associated protein 9") is an enzyme that uses CRISPR sequences as a guide to recognize and open up specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within living organisms.

7. CRISPR Therapeutics - Wikipedia

   en.wikipedia.org/wiki/CRISPR_Therapeutics

   CRISPR Therapeutics has formed collaborations in support of its mission of developing medicines. Vertex Pharmaceuticals and CRISPR Therapeutics entered into a strategic research collaboration in 2015 focused on the use of CRISPR/Cas9 to discover and develop potential new treatments aimed at the underlying genetic causes of human disease. [ 8 ]

8. NHS to offer 'groundbreaking' sickle cell gene therapy - AOL

   www.aol.com/news/nhs-offer-groundbreaking-sickle...

   A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely ...

9. Innovative Genomics Institute - Wikipedia

   en.wikipedia.org/wiki/Innovative_Genomics_Institute

   In addition to CRISPR research, the IGI works to advance public understanding of CRISPR and genome engineering and guide the ethical use of these technologies. Free public resources include: CRISPRpedia — a free textbook-style resource for learning about the biology, applications, and ethics of CRISPR and genome editing, with chapters edited ...